About

ST-segment elevation myocardial infarction (STEMI) remains a leading cause of morbidity and mortality. Challenges in diagnosis remain due to variability in ECG presentation, conditions with similar presentations, variability in the electrical manifestation of ST-segment elevation on ECG, and systems issues with access to rapid diagnosis that can make this diagnosis challenging.

Given the significant morbidity and mortality associated with STEMI, there has been a push to improve the timely diagnosis of STEMI to ensure patients receive therapy faster. However, there remain challenges in diagnosis.

Articles

Foreword

Citation:

US Cardiology Review 2016;10(2):53

New ST-elevation Myocardial Infarction Guidelines Emphasize Speed and Aggressive Treatment and Lower Low-density Lipoprotein Cholesterol Levels

Citation:

US Cardiology 2004;1(1):17–20

ST-segment Elevation Myocardial Infarction in a Patient with Polycythemia Vera Managed with High-dose Tirofiban Pre-treatment, Aspiration Thrombectomy, and Paclitaxel-eluting Stent Implantation

Citation:

US Cardiology 2011;8(1):66–9

Percutaneous Coronary Intervention without On-site Surgical Back-up

Citation:

US Cardiology 2009;6(1):69–74